Toxic metabolites and metabolic soft spots of celastrol based on glutathione metabolic capture and high-resolution mass spectrometry

References

• Lu Y, Liu Y, Zhou J, et al. Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol. Medicinal Research Reviews. 2021 Mar 01;41(2):1022–1060. doi: 10.1002/med.21751
   PubMed Web of Science ®Google Scholar
• Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. 2007;130(5):769–774. doi: 10.1016/j.cell.2007.08.021
   PubMed Web of Science ®Google Scholar
• Zhang Y, Mao X, Li W, et al. Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment. Medicinal Research Reviews. 2021 May 01;41(3):1337–1374. doi: 10.1002/med.21762
   PubMed Web of Science ®Google Scholar
• Wang C, Shi C, Yang X, et al. Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism. Eur J Pharmacol. 2014;744:52–58. doi: 10.1016/j.ejphar.2014.09.043
   PubMed Web of Science ®Google Scholar
• Hong Z, Cao J, Liu D, et al. Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke. J Pharm Anal. 2023 Feb 01;13(2):156–169. doi: 10.1016/j.jpha.2022.12.002
   PubMed Web of Science ®Google Scholar
• Kashyap D, Sharma A, Tuli HS, et al. Molecular targets of celastrol in cancer: recent trends and advancements. Crit Rev Oncol Hematol. 2018 Aug 01;128:70–81.
   PubMed Web of Science ®Google Scholar
• Tong L, Moudgil KD. Celastrus aculeatusMerr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Res Ther. 2007 Jul 23;9(4):R70.
   PubMed Web of Science ®Google Scholar
• Venkatesha SH, Moudgil KD. Celastrol and its role in controlling chronic diseases. In: Gupta S, Prasad S Aggarwal B, editors Anti-inflammatory nutraceuticals and chronic diseases. Cham: Springer International Publishing; 2016. p. 267–289.
   Google Scholar
• Kim DY, Park JW, Jeoung D, et al. Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. Eur J Pharmacol. 2009;612(1–3):98–105. doi: 10.1016/j.ejphar.2009.03.078
   PubMed Web of Science ®Google Scholar
• Cascao R, Vidal B, Raquel H, et al. Effective treatment of rat adjuvant-induced arthritis by celastrol. Autoimmun Rev. 2012;11(12):856–862. doi: 10.1016/j.autrev.2012.02.022
   PubMed Web of Science ®Google Scholar
• Liu J, Lee J, Hernandez MAS, et al. Treatment of obesity with celastrol. Cell. 2015;161(5):999–1011. doi: 10.1016/j.cell.2015.05.011
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Y, Ge H-Y, et al. Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA. J Cell Physiol. 2018 Oct 01;233(10):6814–6824. doi: 10.1002/jcp.26547
   PubMed Web of Science ®Google Scholar
• Moon H-I, Lee J-H, Lee Y-C, et al. Inhibitory effects of isolated compounds from black coloured rice bran on the complement classical pathway. Phytotherapy Research. 2011 Sep 01;25(9):1418–1420. doi: 10.1002/ptr.3485
   PubMed Web of Science ®Google Scholar
• Francis S, Kramarenko I, Brandon C, et al. Celastrol inhibits aminoglycoside-induced ototoxicity via heat shock protein 32. Cell Death Dis. 2011;2(8):e195–e195. doi: 10.1038/cddis.2011.76
   PubMedGoogle Scholar
• Tan J-L, Yi J, Cao X-Y, et al. Celastrol: the new dawn in the treatment of vascular remodeling diseases. Biomed Pharmacother. 2023 Feb 01;158:114177.
   PubMed Web of Science ®Google Scholar
• Hou W, Liu B, Xu H. Celastrol: progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology. Eur J Med Chem. 2020;189:112081. doi: 10.1016/j.ejmech.2020.112081
   PubMed Web of Science ®Google Scholar
• Wang S, Liu K, Wang X, et al. Toxic effects of celastrol on embryonic development of zebrafish (Danio rerio). Drug Chem Toxicol. 2011 Jan 01;34(1):61–65. doi: 10.3109/01480545.2010.494664
   PubMed Web of Science ®Google Scholar
• Sun H, Liu X, Xiong Q, et al. Chronic inhibition of cardiac Kir2.1 and hERG Potassium channels by celastrol with dual effects on both ion Conductivity and protein Trafficking*♦. J Biol Chem. 2006 Mar 03;281(9):5877–5884. doi: 10.1074/jbc.M600072200
   PubMed Web of Science ®Google Scholar
• Bai J-P, Shi Y-L, Fang X, et al. Effects of demethylzeylasteral and celastrol on spermatogenic cell Ca2+ channels and progesterone-induced sperm acrosome reaction. Eur J Pharmacol. 2003 Mar 07;464(1):9–15. doi: 10.1016/S0014-2999(03)01351-7
   PubMed Web of Science ®Google Scholar
• Kusy S, Ghosn EE, Herzenberg LA, et al. Development of B cells and erythrocytes is specifically impaired by the drug celastrol in mice. PLoS One. 2012;7(4):e35733. doi: 10.1371/journal.pone.0035733
   PubMed Web of Science ®Google Scholar
• Sun M, Tang Y, Ding T, et al. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity. Fitoterapia. 2014 Jan 01;92:1–8.
   PubMed Web of Science ®Google Scholar
• Jin C, Wu Z, Wang L, et al. CYP450s-activity relations of celastrol to interact with triptolide reveal the reasons of hepatotoxicity of Tripterygium wilfordii. Molecules. 2019;24(11):2162. doi: 10.3390/molecules24112162
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen Y, Feng X, et al. A comprehensive study of celastrol metabolism in vivo and in vitro using ultra‐high‐performance liquid chromatography coupled with hybrid triple quadrupole time‐of‐flight mass spectrometry. J Sep Sci. 2022;45(6):1222–1239. doi: 10.1002/jssc.202100807
   PubMed Web of Science ®Google Scholar
• Liu J, Lee J, Salazar Hernandez Mario A, et al. Treatment of obesity with Celastrol. Cell. 2015 May 21;161(5):999–1011. doi: 10.1016/j.cell.2015.05.011
   PubMed Web of Science ®Google Scholar